The role of non-invasive modalities for assessing inflammation in patients with non-cystic fibrosis bronchiectasis

Cytokine

Volumn 99, Issue , 2017, Pages 281-286

  Tsikrika, Stamatoula ^a   Dimakou, Katerina ^b   Papaioannou, Andriana I ^c   Hillas, Georgios ^a   Thanos, Loukas ^b   Kostikas, Kostantinos ^c   Loukides, Stelios ^c   Papiris, Spyros ^c   Koulouris, Nickolaos ^a   Bakakos, Petros ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b SOTIRIA GENERAL HOSPITAL   (Greece)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Airway inflammation; Biomarkers; Lung function; Non cf bronchiectasis; Sputum induction

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 13; INTERLEUKIN 8;

ADULT; ARTICLE; ASTHMA; BRONCHIECTASIS; BRONCHODILATATION; CELL COUNT; CELLULAR IMMUNITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; EOSINOPHIL; EOSINOPHILIA; FEMALE; FORCED EXPIRATORY VOLUME; FRACTIONAL EXHALED NITRIC OXIDE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN CELL; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUTROPHIL; NEUTROPHILIA; NON CYSTIC FIBROSIS BRONCHIECTASIS; NON INVASIVE PROCEDURE; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT INFLAMMATION; SPUTUM ANALYSIS; SPUTUM LEVEL; TH1 CELL; TH2 CELL; COMPLICATION; CYSTIC FIBROSIS; DEMOGRAPHY; INFLAMMATION; LUNG FUNCTION TEST; METABOLISM; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA; SEVERITY OF ILLNESS INDEX; SPUTUM;

BRONCHIECTASIS; CELL COUNT; CYSTIC FIBROSIS; DEMOGRAPHY; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-13; INTERLEUKIN-8; MALE; MIDDLE AGED; NEUTROPHILS; PHENOTYPE; PSEUDOMONAS AERUGINOSA; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SPUTUM;

EID: 85028462613     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2017.08.005     Document Type: Article

References (36)

1. Reid, L.M., Reduction in bronchial subdivision in bronchiectasis. Thorax 5:3 (Sep 1950), 233–247.
2. Barker, A.F., Bronchiectasis. N. Engl. J. Med. 346:18 (2002), 1383–1393.
3. Pasteur, M.C., Bilton, D., Hill, A.T., British Thoracic Society guideline for non-CF bronchiectasis. Thorax 65:Suppl. 1 (2010), i1–58.
4. Chalmers, J.D., Smith, M.P., McHugh, B.J., Doherty, C., Govan, J.R., Hill, A.T., Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis. Am. J. Respir. Crit. Care Med. 186:7 (2012), 657–665.
5. Kang, E.Y., Miller, R.R., Muller, N.L., Bronchiectasis: comparison of preoperative thin-section CT and pathologic findings in resected specimens. Radiology 195:3 (1995), 649–654.
6. Paggiaro, P.L., Chanez, P., Holz, O., et al. Sputum induction. Eur. Respir. J. Suppl. 37:September (2002), 3s–8s.
7. Pin, I., Gibson, P.G., Kolendowicz, R., et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 47:1 (1992), 25–29.
8. Foley, S.C., Hopkins, N.O., Fitzgerald, M.X., Donnelly, S.C., McLoughlin, P., Airway nitric oxide output is reduced in bronchiectasis. Respir. Med. 101:7 (2007), 1549–1555.
9. Bakakos, P., Schleich, F., Alchanatis, M., Louis, R., Induced sputum in asthma: from bench to bedside. Curr. Med. Chem. 18:10 (2011), 1415–1422.
10. Bartoli, M.L., Costa, F., Malagrino, L., et al. Sputum inflammatory cells in COPD patients classified according to GOLD 2011 guidelines. Eur. Respir. J. 47:3 (Mar 2016), 978–980.
11. Aliberti, S., Lonni, S., Dore, S., et al. Clinical phenotypes in adult patients with bronchiectasis. Eur. Respir. J. 47:4 (Apr 2016), 1113–1122.
12. Pasteur, M.C., Helliwell, S.M., Houghton, S.J., et al. An investigation into causative factors in patients with bronchiectasis. Am. J. Respir. Crit. Care Med. 162:4 Pt 1 (2000), 1277–1284.
13. Smith, I.E., Jurriaans, E., Diederich, S., Ali, N., Shneerson, J.M., Flower, C.D., Chronic sputum production: correlations between clinical features and findings on high resolution computed tomographic scanning of the chest. Thorax 51:9 (1996), 914–918.
14. Standardization of Spirometry, American Thoracic Society, Am. J. Respir Crit. Care Med. 152(3) (1995) 1107–1136 (1994 Update).
15. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, Am. J. Respir. Crit. Care Med. 171(8) (2005) 912–930 (Apr 15).
16. Kips, J.C., Fahy, J.V., Hargreave, F.E., Ind, P.W., in't Veen, J.C., Methods for sputum induction and analysis of induced sputum: a method for assessing airway inflammation in asthma. Eur. Respir. J. Suppl. 26:March (1998), 9S–12S.
17. Papaporfyriou, A., Tseliou, E., Loukides, S., Kostikas, K., Bakakos, P., Noninvasive evaluation of airway inflammation in patients with severe asthma. Ann. Allergy Asthma Immunol. 110:5 (2013), 316–321.
18. Cowan, D.C., Cowan, J.O., Palmay, R., Williamson, A., Taylor, D.R., Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax 65:5 (2010), 384–390.
19. Tseliou, E., Bakakos, P., Kostikas, K., et al. Increased levels of angiopoietins 1 and 2 in sputum supernatant in severe refractory asthma. Allergy 67:3 (2012), 396–402.
20. Delimpoura, V., Bakakos, P., Tseliou, E., et al. Increased levels of osteopontin in sputum supernatant in severe refractory asthma. Thorax 65:9 (2010), 782–786.
21. Bessa, V., Loukides, S., Hillas, G., et al. Levels of angiopoietins 1 and 2 in induced sputum supernatant in patients with COPD. Cytokine 58:3 (2012), 455–460.
22. Chen, A.C., Martin, M.L., Lourie, R., et al. Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activation. PLoS One., 10(3), 2015, e0119325.
23. Angrill, J., Agusti, C., De Celis, R., et al. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. Am. J. Respir. Crit. Care Med. 164:9 (2001), 1628–1632.
24. Bals, R., Hiemstra, P.S., Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur. Respir. J. 23:2 (2004), 327–333.
25. Shoemark, A., Devaraj, A., Meister, M., Ozerovitch, L., Hansell, D.M., Wilson, R., Elevated peripheral airway nitric oxide in bronchiectasis reflects disease severity. Respir. Med. 105:6 (2011), 885–891.
26. Dimakou, K., Triantafillidou, C., Toumbis, M., Tsikritsaki, K., Malagari, K., Bakakos, P., Non CF-bronchiectasis: aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients. Respir. Med. 116:July (2016), 1–7.
27. George, L., Brightling, C.E., Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease. Ther. Adv. Chronic Dis. 7:1 (2016), 34–51.
28. Woltmann, G., McNulty, C.A., Dewson, G., Symon, F.A., Wardlaw, A.J., Interleukin-13 induces PSGL-1/P-selectin-dependent adhesion of eosinophils, but not neutrophils, to human umbilical vein endothelial cells under flow. Blood 95:10 (2000), 3146–3152.
29. Cho, Y.J., Lim, H.J., Park, J.S., Lee, J.H., Lee, C.T., Yoon, H.I., Measurement of fractional exhaled nitric oxide in stable bronchiectasis. Tuberc Respir Dis (Seoul). 74:1 (2013), 7–14.
30. Dente, F.L., Bilotta, M., Bartoli, M.L., et al. Neutrophilic bronchial inflammation correlates with clinical and functional findings in patients with noncystic fibrosis bronchiectasis. Mediators Inflamm., 2015, 2015, 642503.
31. Davies, G., Wells, A.U., Doffman, S., Watanabe, S., Wilson, R., The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis. Eur. Respir. J. 28:5 (2006), 974–979.
32. Evans, S.A., Turner, S.M., Bosch, B.J., Hardy, C.C., Woodhead, M.A., Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa. Eur. Respir. J. 9:8 (1996), 1601–1604.
33. Rogers, G.B., van der Gast, C.J., Cuthbertson, L., et al. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Thorax 68:8 (2013), 731–737.
34. Cano, N.J., Pichard, C., Roth, H., et al. C-reactive protein and body mass index predict outcome in end-stage respiratory failure. Chest 126:2 (2004), 540–546.
35. Telenga, E.D., Kerstjens, H.A., Ten Hacken, N.H., Postma, D.S., van den Berge, M., Inflammation and corticosteroid responsiveness in ex-, current- and never-smoking asthmatics. BMC Pulm Med., 13, 2013, 58.
36. McShane, P.J., Naureckas, E.T., Tino, G., Strek, M.E., Non-cystic fibrosis bronchiectasis. Am. J. Respir. Crit. Care Med. 188:6 (2013), 647–656.